Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 2/20 | 0.40 |
| ▸ | MAOB | P27338 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.36 |
| ▸ | RECQL | P46063 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL31191863 | 0.84 | ALDH1A1 (0.38) | ALDH1A1TSHRTHRBKDM4ERECQL | |
| SCHEMBL8337374 | 0.83 | MAOA (0.41) | MAOAMAOBALDH1A1TSHRKDM4E | |
| SCHEMBL18057188 | 0.83 | KDM4E (0.40) | MAOAMAOBALDH1A1TSHRTHRB | |
| SCHEMBL30648987 | 0.81 | ALDH1A1 (0.42) | ALDH1A1TSHRTHRBKDM4ERECQL | |
| SCHEMBL25148186 | 0.81 | ALDH1A1 (0.47) | ALDH1A1TSHRTHRBKDM4ERECQL | |
| SCHEMBL20254234 | 0.81 | ALDH1A1 (0.38) | ALDH1A1TSHRTHRBKDM4EEPHX2 | |
| SCHEMBL10962985 | 0.79 | KDM4E (0.47) | ALDH1A1TSHRTHRBKDM4ERECQL | |
| SCHEMBL5933120 | 0.79 | KDM4E (0.47) | ALDH1A1TSHRTHRBKDM4ERECQL | |
| SCHEMBL7704761 | 0.79 | MAOA (0.46) | MAOAMAOBTSHRTHRBMEN1 | |
| SCHEMBL8333250 | 0.79 | MAOA (0.44) | MAOAMAOBALDH1A1TSHRKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025151423-A1 | ANTI-CD24 ANTIBODY DRUG CONJUGATES AND USES THEREOF | OncoC4, Inc. (US) | 2025-07-17 | — | — | WO | claimed |
| US-20250387493-A1 | METHOD OF ABROGATING ANTI-DRUG ANTIBODY FORMATION, AND DRUG CONJUGATES FOR USE THEREIN | ONCOC4 INC (US) | 2025-12-25 | — | — | US | disclosed |
| WO-2025151423-A1 | ANTI-CD24 ANTIBODY DRUG CONJUGATES AND USES THEREOF | OncoC4, Inc. (US) | 2025-07-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250387493-A1 | METHOD OF ABROGATING ANTI-DRUG ANTIBODY FORMATION, AND DRUG CONJUGATES FOR USE THEREIN | CD47, TTL, TNFSF10 | MAOA 2353/4885MAOB 3189/4885ALDH1A1 1936/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.